PROQR THERAPEUTICS EO-04 (0PQ) — Free Cash Flow Generation Index

Latest as of December 2023: 0.94x

PROQR THERAPEUTICS EO-04 (0PQ) has a Free Cash Flow Generation Index of 0.94x as of December 2023. Free cash flow of €20.18 Million represents 1% of operating cash flow (€21.55 Million). Explore 0PQ capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.94x
Free Cash Flow / Operating CF

Free Cash Flow

€20.18 Million
EUR

Operating Cash Flow

€21.55 Million
EUR

Capital Expenditures

€1.37 Million
EUR

PROQR THERAPEUTICS EO-04 Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for PROQR THERAPEUTICS EO-04 across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does PROQR THERAPEUTICS EO-04 generate cash.

Annual Free Cash Flow Generation for PROQR THERAPEUTICS EO-04 (2023–2023)

Year-by-year Free Cash Flow Generation Index for PROQR THERAPEUTICS EO-04. Check cash flow reinvestment rate of PROQR THERAPEUTICS EO-04 to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2023 0.94x €20.18 Million €21.55 Million €1.37 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).